Unknown

Dataset Information

Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules.


ABSTRACT:

Background

The number of pulmonary nodules detected in the US is expected to increase substantially following recent recommendations for nationwide CT-based lung cancer screening. Given the low specificity of CT screening, non-invasive adjuvant methods are needed to differentiate cancerous lesions from benign nodules to help avoid unnecessary invasive procedures in the asymptomatic population. We have constructed a serum-based multi-biomarker panel and assessed its clinical accuracy in a retrospective analysis of samples collected from participants with suspicious radiographic findings in the Prostate, Lung, Chest and Ovarian (PLCO) cancer screening trial.

Methods

Starting with a set of 9 candidate biomarkers, we identified 8 that exhibited limited pre-analytical variability

SUBMITTER: Birse CE 

PROVIDER: S-EPMC5498919 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature